|2.54||+0.17 / +7.17%|
Data as of 4:00pm ET
|2.52||-0.02 / -0.79%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +96.85% increase from the last price of 2.54.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.